Cytosorbents Corp CTSO Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$4.60 up $0.04, 0.88% at close Nov 5
Last close · Previous close $4.56
- Market cap
- At the Nov 5 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- Last 12 months
Price chart
$4.60up $0.04, 0.88%Thu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$4.56Nov 4
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Valuation
Financials
Dividends
About Cytosorbents Corp
CytoSorbents Corporation, formerly MedaSorb Technologies Corporation is a development-stage therapeutic medical device company. As of December 31, 2011, the Company had developed and focuses on commercializing a blood purification technology that would be able to remove middle molecular weight toxins from circulating blood and physiologic fluids. The Company has developed two products, CytoSorb and BetaSorb utilizing its adsorbent polymer technology. These products are known medically as hemoperfusion devices. As of December 31, 2011, the Company had initiated and opened for enrollment a total of 14 hospital units to participate in its clinical study. The CytoSorb device consists of a cartridge containing adsorbent polymer beads, that are intended to remove toxins and other substances from blood and physiologic fluids. The cartridge incorporates connectors at either end of the device, which connect directly to an extra-corporeal circuit (bloodlines) on a stand alone basis.
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
CTSO news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
CTSO stock FAQ
What is CTSO stock’s price today?
Cytosorbents (CTSO) traded at $4.60 at the close on , up $0.04 (0.88%) from the previous close of $4.56.
What exchange does CTSO trade on?
Cytosorbents trades on the Nasdaq under the ticker symbol CTSO. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.